| DFSVX | PCVCX | DFSVX / PCVCX | |
| Total Expense Ratio | 0.31 | 1.92 | 16% |
| Annual Report Gross Expense Ratio | 0.31 | 2.03 | 15% |
| Fund Existence | 33 years | 29 years | - |
| Gain YTD | 1.243 | -6.224 | -20% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 15.5B | 236M | 6,568% |
| Annual Yield % from dividends | 1.69 | 0.65 | 262% |
| Returns for 1 year | -3.14 | -14.24 | 22% |
| Returns for 3 years | 17.48 | -18.09 | -97% |
| Returns for 5 years | 60.60 | -15.72 | -385% |
| Returns for 10 years | 53.59 | -56.93 | -94% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BIB | 77.91 | 1.17 | +1.53% |
| ProShares Ultra Nasdaq Biotechnology | |||
| BCOR | 27.20 | 0.23 | +0.83% |
| Grayscale Bitcoin Adopters ETF | |||
| DFNL | 44.57 | 0.17 | +0.39% |
| Davis Select Financial ETF | |||
| BZQ | 8.02 | 0.03 | +0.38% |
| ProShares UltraShort MSCI Brazil Capped | |||
| PXH | 25.80 | -0.06 | -0.21% |
| Invesco RAFI Emerging Markets ETF | |||